SAN FRANCISCO, June 21, 2018 /PRNewswire/ --
The global artificial insemination market is expected toreach USD 2.63 billion by 2025, according to a new report by Grand View Research, Inc. Over the past few years, infertility has become a major public health concern across the globe. Artificial insemination is usually the
(Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )
The exact estimation of infertility statistics is challenging, however, WHO monitors its prevalence across the world. At present, 46% of the global population lives in countries having low levels of fertility. According to United Nations, the global rate of fertility is expected to decline to 2.4 by 2030 and 2.2 by 2050. In developing or underdeveloped nations, medical consultation regarding infertility and childlessness was not easily accessible. Hence, there was lack of awareness about available assisted reproductive techniques including artificial or donor insemination and IVF
Browse full research report with TOC on "Artificial Insemination Market Analysis By Type (Intrauterine Insemination, Intracervical Insemination, Intravaginal Insemination), By End-use, By Source Type, And Segment Forecasts, 2018 - 2025" at: https://www.grandviewresearch.com/industry-analysis/artificial-insemination-market
Further Key Findings From the Report Suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the Artificial Insemination market based on type, end use, source type and region:
Explore the BI enabled intuitive market research database, The Grand Library, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: +1-415-349-0058 Toll Free: 1-888-202-9519 Email: firstname.lastname@example.org
SOURCE Grand View Research, Inc.
Subscribe to our Free Newsletters!
Complex regional pain syndrome (CRPS) is rare chronic pain disorder usually involving an arm or ...
Polyarthritis refers to pain in four or more joints simultaneously due to various causes ranging ...
Gardner or Gardner''s syndrome, also known as familial adenomatous polyposis (FAP), is an autosomal ...View All